Key result
BTK inhibitors linked to cardiovascular complications requiring targeted clinical management.
Key points are not available for this paper at this time.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Tang et al. (2021) studied this question. Bruton tyrosine kinase inhibitors are associated with cardiovascular complications that require specific clinical management strategies.
Synapse has enriched 5 related papers. Consider them for comparative context: